Latest Leadership Change News

Vonex Limited reported a significantly reduced net loss for FY25 alongside a strengthened balance sheet, operational upgrades, and a pending acquisition by Maxo Telecommunications. The company is navigating going concern uncertainties while advancing network expansion and governance reforms.

Apiam Animal Health posted modest FY25 growth amid challenges in clinical services, launching a Strategic Reset Program and attracting an acquisition proposal from Adamantem Capital.

Apiam Animal Health reported modest revenue growth but a sharp net profit decline in FY25, launching a Strategic Reset program under new leadership. The company also received a $0.88 per share acquisition proposal from Adamantem Capital Management.

Domino’s Pizza Enterprises reported flat network sales and a modest decline in earnings for FY25, unveiling a comprehensive strategic reset focused on cost reduction, franchisee profitability, and market-specific turnarounds.

Domino’s Pizza Enterprises Limited reported a statutory net loss for FY25, closing 312 underperforming stores and navigating significant leadership changes while declaring an unfranked final dividend.

Pioneer Credit Limited has reported a significant turnaround in FY25, posting a net profit after tax of $6.7 million compared to a loss of $10 million the previous year, supported by improved operational efficiency and strengthened debt facilities.

Golden State Mining announces key executive departures and cost-saving measures as part of a strategic cash preservation plan.

Meridian Energy posted a significant net loss for FY25 due to severe droughts and gas shortages but pushed ahead with renewable investments and maintained shareholder dividends.

Yancoal Australia has appointed Sharif Burra as its permanent CEO, signaling leadership continuity amid a challenging coal market. Burra’s deep internal experience positions him to build on recent operational gains and shareholder value.

Race Oncology Limited reported a significantly reduced loss for FY2025, driven by key clinical trial progress and strategic leadership changes. The company advances its RC220 program with promising Phase 1 dosing milestones and strengthens its governance to support future growth.

Ironbark Capital Limited reported a 17.6% increase in net profit for FY2025, driven by higher investment income and realised gains, alongside a raised fully franked dividend and an extended share buy-back program.

Eildon Capital Group reported a net loss of $5.7 million for FY2025, weighed down by significant one-off impairments, while pivoting to focused real estate investments with a new $20.8 million joint venture in Queensland.